Inyx

IYXI · OTC

$0.00+$0.00 (+0.00%)TodayMarket open · Nov 7, 3:22 PM ET · Delayed 15 min

No price history for this range.

About IYXI

Inyx, Inc. is pharmaceutical company, which develops and acquires niche pharmaceutical products and drug delivery systems for key therapeutic areas, including respiratory and dermatological applications. The company is headquartered in New York City, New York and currently employs 572 full-time employees. The company went IPO on 2003-02-19. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.

Employees: 572
Headquarters: New York City, New York
Listed: Feb 19, 2003
Sector: Health Care
Industry: Pharmaceuticals

Leadership

Inyx executives
Name	Title	Since	Age
Jack Kachkar	—	—	45
Steven Handley	—	2007	45
Colin Hunter	—	2007	51
Jay Green	—	—	59
Stephen Beckman	—	—	41
William Kelly	—	—	—

Similar companies

Companies in the same industry as Inyx

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.